Clinical Research Directory
Browse clinical research sites, groups, and studies.
eHealth in Treatment of Gestational Diabetes (eMOMGDM)
Sponsor: Helsinki University Central Hospital
Summary
The overall aim of the eMOM GDM-project is to develop and evaluate a novel system to clinical decision making and patient behavior change in treatment of GDM, combining diet, physical activity, sleep, heart rate (e.g. stress), and glucose monitoring within a single system (the eMOM GDM application), and linking the developed application tool for the normal health care system in a new way. In this second phase of the project, the effect of eMOM GDM application on maternal and neonatal outcomes will be evaluated in a randomized controlled study design. The follow-up study continues until 3 months postpartum.
Official title: eHealth in Treatment of Gestational Diabetes - eMOM GDM -Study (Phase 2)
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-03-10
Completion Date
2026-12-31
Last Updated
2024-12-12
Healthy Volunteers
Yes
Conditions
Interventions
eMOM GDM application
Participants in the intervention group will use the eMOM GDM -application one week/month. eMOM GDM application includes: * continuous glucose monitor (CGM, Medtronic) * diet (digital food tracker) (min 3 days during one application week) * heartrate, stress and physical activity with the wrist-worn activity tracker (Vivosmart 3) * weight measured once a week The sensors can be worn and the application used during the whole pregnancy (if a mother is interested in)
Locations (1)
Helsinki University Hospital
Helsinki, Finland